Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunological Memory01:23

Immunological Memory

2.0K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
2.0K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

2.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
2.0K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.5K
Overview
69.5K
Vaccinations01:51

Vaccinations

45.1K
Overview
45.1K
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

959
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
959
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

858
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
858

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Curcumin Synergistically Sensitizes Multidrug-Resistant Lung Cancer to Doxorubicin Through Ferroptosis-Associated Oxidative Stress.

Antioxidants (Basel, Switzerland)·2026
Same author

Targeting BMP2 signaling pathway in osteogenesis and osteoarthritis: A path toward safer regenerative therapies.

Cellular signalling·2026
Same author

Cytotoxicity and Cellular Mechanisms of Novel Polymeric 2,4D Nanopesticide on Human Lung Epithelial A549 Cells.

ACS omega·2026
Same author

Oral exposure to polystyrene nanoplastics induces anxiety-like behavior and cognitive deficit accompanied with alteration of neuroimmune markers in rats.

The Journal of toxicological sciences·2025
Same author

Evaluation of hydrogel loading with curcumin and silver nanoparticles: biocompatibilities and anti-biofilm activities.

Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine·2025
Same author

Evaluation of curcumin nanoparticles of various sizes for targeting multidrug-resistant lung cancer cells via inhalation.

Nanomedicine (London, England)·2024

Related Experiment Video

Updated: Aug 8, 2025

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.2K

Employing T-Cell Memory to Effectively Target SARS-CoV-2.

Zaw Htet Tun1, Nang Thinn Thinn Htike1, Chaw Kyi-Tha-Thu2

  • 1Faculty of Medicine, Royal College of Medicine Perak, Universiti Kuala Lumpur (UniKL RCMP), Ipoh 30450, Perak, Malaysia.

Pathogens (Basel, Switzerland)
|February 25, 2023
PubMed
Summary

Next-generation vaccines aim to improve T-cell immunity for better viral containment against SARS-CoV-2. This review explores vaccine strategies to enhance T-cell memory responses for broader and faster protection.

Keywords:
COVID-19SARS-CoV-2T cellslung TRMvaccine

More Related Videos

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

387
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.3K

Related Experiment Videos

Last Updated: Aug 8, 2025

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype
08:49

Transduction and Expansion of Primary T Cells in Nine Days with Maintenance of Central Memory Phenotype

Published on: March 18, 2020

11.2K
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
06:10

Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates

Published on: May 9, 2025

387
Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle
15:57

Application of Long-term cultured Interferon-γ Enzyme-linked Immunospot Assay for Assessing Effector and Memory T Cell Responses in Cattle

Published on: July 11, 2015

12.3K

Area of Science:

  • Immunology
  • Vaccinology
  • Virology

Background:

  • Effective T-cell immunity is crucial for controlling viral infections like SARS-CoV-2.
  • While convalescent SARS-CoV-2 cases develop memory T cells, some exhibit abnormalities, and new strains may evade existing immunity.
  • First-generation vaccines established T-cell immunity, but mutant strains challenge their effectiveness.

Purpose of the Study:

  • To review vaccine approaches for educating T-cell memory.
  • To discuss strategies for triggering broad and rapid T-cell responses targeting multiple viral proteins.
  • To highlight essential facts and potential future consequences of current vaccine use.

Main Methods:

  • Review of current scientific literature on T-cell immunity and vaccine development.
  • Analysis of strategies for next-generation vaccine design.
  • Discussion of T-cell memory shaping for viral containment.

Main Results:

  • Several promising vaccine approaches are being explored to enhance T-cell memory.
  • Next-generation vaccines aim to induce faster and broader T-cell responses against diverse viral targets.
  • Understanding T-cell responses is key to overcoming challenges posed by viral mutations.

Conclusions:

  • Optimizing T-cell immunity through advanced vaccine strategies is vital for efficient viral containment.
  • Future vaccines must elicit robust and adaptable T-cell memory to counter evolving viral threats.
  • Further research is needed to assess the long-term impact and efficacy of novel vaccine approaches.